Get it on Google Play

FDA Panel Backs Auxilium's (AUXL) XIAFLEX

September 16, 2009 3:07 PM EDT Send to a Friend
A FDA panel is backing Auxilium Pharmaceuticals (Nasdaq: AUXL) XIAFLEX drug to treat Dupuytren's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login